Aledort, L. M.
~ 100  Ergebnisse:
?
2

The EPIC study: a lesson to learn:

Auerswald, G. ; Kurnik, K. ; Aledort, L. M....
Haemophilia.  21 (2015)  5 - p. 622-628 , 2015
 
?
5

Harmonization of clinical trial guidelines for assessing th..:

ALEDORT, L. M.
Journal of Thrombosis and Haemostasis.  9 (2011)  3 - p. 423-427 , 2011
 
?
6

Can B-domain deletion alter the immunogenicity of recombina..:

ALEDORT, L. M. ; NAVICKIS, R. J. ; WILKES, M. M.
Journal of Thrombosis and Haemostasis.  9 (2011)  11 - p. 2180-2192 , 2011
 
?
7

Best evidence on B-domain deletion and the immunogenicity o..:

ALEDORT, L. M. ; NAVICKIS, R. J. ; WILKES, M. M.
Journal of Thrombosis and Haemostasis.  9 (2011)  11 - p. 2325-2327 , 2011
 
?
8

Another role for the VW molecule:

ALEDORT, L. M.
Haemophilia.  18 (2011)  2 - p. 246-247 , 2011
 
?
9

Evaluation of bleeding and thrombotic events during long-te..:

GERNSHEIMER, T. B. ; GEORGE, J. N. ; ALEDORT, L. M....
Journal of Thrombosis and Haemostasis.  8 (2010)  6 - p. 1372-1382 , 2010
 
?
 
?
11

To bleed or not to bleed - is that a question?:

ALEDORT, L. M.
Journal of Thrombosis and Haemostasis.  8 (2010)  1 - p. 81-82 , 2010
 
?
14

Mild and moderate factor VIII deficiency: inhibitor risks:

ALEDORT, L. M.
Journal of Thrombosis and Haemostasis.  7 (2009)  6 - p. 928-929 , 2009
 
?
15

Reconstruction of the Hepatitis C Virus Epidemic in the US ..:

Goedert, J. J. ; Chen, B. E. ; Preiss, L....
American Journal of Epidemiology.  165 (2007)  12 - p. 1443-1453 , 2007
 
1-15